Hee Youn Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hee Youn Kim has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Seung-Ju Lee
Department of Urology, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea
8 shared publications - Dong Sup Lee
Department of Urology, St. Vincent’s Hospital, The Catholic University of Korea, Suwon, Korea
7 shared publications Je Mo Yoo
Department of Urology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
3 shared publications- Je Mo Yoo
Department of Urology, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea
3 shared publications - Jin Bong Choi
Department of Urology, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
3 shared publications Young Hyo Choi
Department of Urology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
3 shared publications
Latest Publications
- Open Access
- 13 May 2026
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 52, 1-6
Multicenter Study on Integrating Prostate Magnetic Resonance Imaging with Prostate-Specific Antigen Density for Risk-Adapted Biopsy Strategy in a South Korean Cohort
Objective: Combining Prostate Imaging-Reporting and Data System (PI-RADS) with prostate-specific antigen density (PSAD) may improve the detection of clinically significant prostate cancer (csPCa) while reducing unnecessary biopsies. This study aimed to evaluate csPCa detection rates using PI-RADS and PSAD, identify optimal PSAD cutoffs, and assess biopsy strategies to optimize csPCa detection and reduce unnecessary procedures within a South Korean cohort. Methods: This multicenter retrospective study included 3117 biopsy-naïve patients from 2 tertiary hospitals in South Korea (2020-2025) who underwent magnetic resonance imaging–based transperineal prostate biopsy. Patients were stratified into PI-RADS groups (1-2, 3, 4-5) and PSAD categories (<0.10, 0.10-0.15, 0.15-0.20, and ≥0.20). Receiver-operating characteristic (ROC) curve analyses validated PSAD cut-offs, and biopsy strategies were compared for csPCa detection and biopsy avoidance. Results: The overall csPCa detection rate was 47.1%. PI-RADS 4-5 patients had high detection rates across all PSAD levels (20.1%-76.5%), while PI-RADS 1-2 and 3 patients with PSAD ≥ 0.15 showed elevated rates (15.2%-16.9% and 25.0%-35.7%, respectively). ROC curve analyses identified optimal PSAD cut-offs of 0.155 (area under the ROC curve (AUC), 0.708) for PI-RADS 1-2 and 0.145 (AUC, 0.749) for PI-RADS 3. The proposed strategy (PI-RADS ≥ 4 or PI-RADS 1-2 or 3 with PSAD ≥ 0.15) outperformed other strategies, avoiding 448 (14.4%) biopsies, missing 28 (1.9%) csPCa cases, and achieving a negative predictive value of 93.8%. Conclusion: Integrating PI-RADS with PSAD enhances risk stratification for csPCa, maintaining high diagnostic accuracy while reducing unnecessary procedures. Cite this article as: Lee SJ, Shin DH, Kim HY. Multicenter study on integrating prostate magnetic resonance imaging with prostate-specific antigen density for risk-adapted biopsy strategy in a South Korean cohort. Urol Res Pract. 2026, 52, 0014, doi: 10.5152/tud.2026.26014.
- 13 May 2026
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 52, 1-6
Open AccessMulticenter Study on Integrating Prostate Magnetic Resonance Imaging with Prostate-Specific Antigen Density for Risk-Adapted Biopsy Strategy in a South Korean Cohort
Objective: Combining Prostate Imaging-Reporting and Data System (PI-RADS) with prostate-specific antigen density (PSAD) may improve the detection of clinically significant prostate cancer (csPCa) while reducing unnecessary biopsies. This study aimed to evaluate csPCa detection rates using PI-RADS and PSAD, identify optimal PSAD cutoffs, and assess biopsy strategies to optimize csPCa detection and reduce unnecessary procedures within a South Korean cohort. Methods: This multicenter retrospective study included 3117 biopsy-naïve patients from 2 tertiary hospitals in South Korea (2020-2025) who underwent magnetic resonance imaging–based transperineal prostate biopsy. Patients were stratified into PI-RADS groups (1-2, 3, 4-5) and PSAD categories (<0.10, 0.10-0.15, 0.15-0.20, and ≥0.20). Receiver-operating characteristic (ROC) curve analyses validated PSAD cut-offs, and biopsy strategies were compared for csPCa detection and biopsy avoidance. Results: The overall csPCa detection rate was 47.1%. PI-RADS 4-5 patients had high detection rates across all PSAD levels (20.1%-76.5%), while PI-RADS 1-2 and 3 patients with PSAD ≥ 0.15 showed elevated rates (15.2%-16.9% and 25.0%-35.7%, respectively). ROC curve analyses identified optimal PSAD cut-offs of 0.155 (area under the ROC curve (AUC), 0.708) for PI-RADS 1-2 and 0.145 (AUC, 0.749) for PI-RADS 3. The proposed strategy (PI-RADS ≥ 4 or PI-RADS 1-2 or 3 with PSAD ≥ 0.15) outperformed other strategies, avoiding 448 (14.4%) biopsies, missing 28 (1.9%) csPCa cases, and achieving a negative predictive value of 93.8%. Conclusion: Integrating PI-RADS with PSAD enhances risk stratification for csPCa, maintaining high diagnostic accuracy while reducing unnecessary procedures. Cite this article as: Lee SJ, Shin DH, Kim HY. Multicenter study on integrating prostate magnetic resonance imaging with prostate-specific antigen density for risk-adapted biopsy strategy in a South Korean cohort. Urol Res Pract. 2026, 52, 0014, doi: 10.5152/tud.2026.26014.
- Open Access
- 1 January 2025
- Published by XMLink in The World Journal of Men's Health
- Vol. 43
The Biomolecular Effects of Finasteride on Male Rat Brain during Administration and after Discontinuation
Choi YH, et al. World J Mens Health. 2025 Sep;43:e75. https://doi.org/10.5534/wjmh.250105
- 1 January 2025
- Published by XMLink in The World Journal of Men's Health
- Vol. 43
Open AccessThe Biomolecular Effects of Finasteride on Male Rat Brain during Administration and after Discontinuation
Choi YH, et al. World J Mens Health. 2025 Sep;43:e75. https://doi.org/10.5534/wjmh.250105
- Open Access
- 1 January 2025
- Published by XMLink in Investigative and Clinical Urology
- Vol. 66 (3) , 261-271
Effect of long-term postoperative OM-89 administration on bacteriuria from suspected infectious stones
Lee SJ, et al. Investig Clin Urol. 2025 May;66(3):261-271. https://doi.org/10.4111/icu.20250086
- 1 January 2025
- Published by XMLink in Investigative and Clinical Urology
- Vol. 66 (3) , 261-271
Open AccessEffect of long-term postoperative OM-89 administration on bacteriuria from suspected infectious stones
Lee SJ, et al. Investig Clin Urol. 2025 May;66(3):261-271. https://doi.org/10.4111/icu.20250086
- Open Access
- 31 December 2024
- Published by Elsevier in Prostate International
- Vol. 13 (2) , 107-111
Use versus nonuse of antimicrobial prophylaxis prior to transperineal prostate biopsy: a propensity score-matched analysis
- 31 December 2024
- Published by Elsevier in Prostate International
- Vol. 13 (2) , 107-111
Open AccessUse versus nonuse of antimicrobial prophylaxis prior to transperineal prostate biopsy: a propensity score-matched analysis
- 6 June 2024
- Published by Elsevier in European Journal of Pharmacology
- Vol. 977, 176721
Pirfenidone improves voiding function by suppressing bladder fibrosis in underactive bladder rats
- 6 June 2024
- Published by Elsevier in European Journal of Pharmacology
- Vol. 977, 176721
Pirfenidone improves voiding function by suppressing bladder fibrosis in underactive bladder rats
- Open Access
- 31 March 2024
- Published by Korean Continence Society in International Neurourology Journal
- Vol. 28 (1) , 67-69
Water Vapor Therapy and Zonal Anatomy of the Prostate
Water vapor therapy using Rezūm has been recently introduced as a minimally invasive surgery for benign prostatic hyperplasia and is being increasingly performed. However, there is a lack of real-time images showing this practice and how convective water vapor acts in the prostate gland. In real-time ultrasonography, convective water vapor rapidly spreads throughout the ipsilateral transitional zone and is mostly limited within the transitional zone. For educational purposes, we would like to present a case to help readers understand water vapor therapy by visualizing convective water vapor using real-time ultrasound.
- 31 March 2024
- Published by Korean Continence Society in International Neurourology Journal
- Vol. 28 (1) , 67-69
Open AccessWater Vapor Therapy and Zonal Anatomy of the Prostate
Water vapor therapy using Rezūm has been recently introduced as a minimally invasive surgery for benign prostatic hyperplasia and is being increasingly performed. However, there is a lack of real-time images showing this practice and how convective water vapor acts in the prostate gland. In real-time ultrasonography, convective water vapor rapidly spreads throughout the ipsilateral transitional zone and is mostly limited within the transitional zone. For educational purposes, we would like to present a case to help readers understand water vapor therapy by visualizing convective water vapor using real-time ultrasound.
- Open Access
- 19 December 2023
- Published by Springer Nature in BMC Urology
- Vol. 23 (1) , 1-7
Efficacy of fosfomycin compared to second generation cephalosporin flumarin as antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: a single center retrospective study
Background: Fluoroquinolone has been the historic choice of antimicrobial prophylaxis for transrectal ultrasound (TRUS) guided prostate biopsy. However, increased fluoroquinolone resistance and recent restrictions of its use for antimicrobial prophylaxis has led to the emergence of alternative agents for antimicrobial prophylaxis for TRUS guided prostate biopsy including fosfomycin and cephalosporins. This study aimed to compare the efficacy of fosfomycin and a second-generation cephalosporin flumarin as alternative antimicrobials for TRUS-guided prostate biopsy in terms of the incidence of infectious complications after TRUS-guided prostate biopsy. Methods: A retrospective chart review of all patients who underwent TRUS-guided prostate biopsy between November 2009 to January 2023 was undertaken. Comparison of baseline characteristics and the incidence of infectious complications was done between those who received fosfomycin as antimicrobial prophylaxis for TRUS-guided prostate biopsy and those who received flumarin. Multivariate logistic regression analysis was conducted to identify risk factors for infectious complications after TRUS-guided prostate biopsy. Results: Of 2,900 patients identified as eligible candidates for analysis, 333 (11.5%) received fosfomycin and 2,567 (88.5%) received flumarin. The overall rate of infectious complications was approximately 3% lower in patients who received fosfomycin, although such difference did not reach statistical significance (5.7% vs. 8.6%, p = 0.074). Multivariate logistic regression analysis showed that history of operation done under general anaesthesia within six months of the biopsy (odds ratio [OR]: 2.216; 95% confidence interval [CI]: 1.042–4.713; p = 0.039) and history of prior antimicrobial use within six months (OR: 1.457; 95% CI: 1.049–2.024; p = 0.025) were significant risk factors for infectious complications after TRUS-guided prostate biopsy. Conclusion: Fosfomycin was comparable to second-generation cephalosporin flumarin in preventing infectious complications after TRUS-guided prostate biopsy. Coupled with its properties such as ease of administration, low adverse effects, low resistance rate, and low collateral damage, fosfomycin might be an attractive alternative antimicrobial prophylaxis for TRUS-guided prostate biopsy.
- 19 December 2023
- Published by Springer Nature in BMC Urology
- Vol. 23 (1) , 1-7
Open AccessEfficacy of fosfomycin compared to second generation cephalosporin flumarin as antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: a single center retrospective study
Background: Fluoroquinolone has been the historic choice of antimicrobial prophylaxis for transrectal ultrasound (TRUS) guided prostate biopsy. However, increased fluoroquinolone resistance and recent restrictions of its use for antimicrobial prophylaxis has led to the emergence of alternative agents for antimicrobial prophylaxis for TRUS guided prostate biopsy including fosfomycin and cephalosporins. This study aimed to compare the efficacy of fosfomycin and a second-generation cephalosporin flumarin as alternative antimicrobials for TRUS-guided prostate biopsy in terms of the incidence of infectious complications after TRUS-guided prostate biopsy. Methods: A retrospective chart review of all patients who underwent TRUS-guided prostate biopsy between November 2009 to January 2023 was undertaken. Comparison of baseline characteristics and the incidence of infectious complications was done between those who received fosfomycin as antimicrobial prophylaxis for TRUS-guided prostate biopsy and those who received flumarin. Multivariate logistic regression analysis was conducted to identify risk factors for infectious complications after TRUS-guided prostate biopsy. Results: Of 2,900 patients identified as eligible candidates for analysis, 333 (11.5%) received fosfomycin and 2,567 (88.5%) received flumarin. The overall rate of infectious complications was approximately 3% lower in patients who received fosfomycin, although such difference did not reach statistical significance (5.7% vs. 8.6%, p = 0.074). Multivariate logistic regression analysis showed that history of operation done under general anaesthesia within six months of the biopsy (odds ratio [OR]: 2.216; 95% confidence interval [CI]: 1.042–4.713; p = 0.039) and history of prior antimicrobial use within six months (OR: 1.457; 95% CI: 1.049–2.024; p = 0.025) were significant risk factors for infectious complications after TRUS-guided prostate biopsy. Conclusion: Fosfomycin was comparable to second-generation cephalosporin flumarin in preventing infectious complications after TRUS-guided prostate biopsy. Coupled with its properties such as ease of administration, low adverse effects, low resistance rate, and low collateral damage, fosfomycin might be an attractive alternative antimicrobial prophylaxis for TRUS-guided prostate biopsy.
- 5 February 2022
- Published by Springer Nature in Urolithiasis
- Vol. 50 (3) , 375-380
Effect of a three-dimensional (3D) printed kidney model on patient understanding of the percutaneous nephrolithotomy procedure: a preliminary study
Three-dimensional (3D) printed anatomical models can provide cognitive anatomical information. We aimed to study the effect of a 3D printed kidney model on patient understanding of kidney anatomy and the percutaneous nephrolithotomy (PCNL) procedure as well as the overall patient satisfaction with the model. Seven patients who underwent PCNL were enrolled in the study. Personalized 3D printed kidney models were constructed based on the patients’ computed tomography images. Patients completed two questionnaires regarding their understanding and satisfaction with the use of the 3D printed kidney model before and after using the model during informed consent. The mean age of the study population was 58.0 years. Comparison of patient understanding and satisfaction between the two questionnaires showed a general trend toward better understanding and improved satisfaction with use of 3D printed kidney models. Statistically significant results were seen for understanding of kidney anatomy, stone size, procedure, and satisfaction (p values 0.046, 0.025, 0.046, and 0.046, respectively). Five of the seven patients (71.4%) answered that the model was very useful. However, none of the patients answered that the cost was appropriate. In the current study, patients showed improved understanding of the kidney anatomy and the PCNL procedure and higher satisfaction with using the 3D printed kidney model during informed consent. With further studies using larger patient numbers and decreased production cost, using 3D printed kidney models has the potential to be a useful adjunct for patient understanding during PCNL.
- 5 February 2022
- Published by Springer Nature in Urolithiasis
- Vol. 50 (3) , 375-380
Effect of a three-dimensional (3D) printed kidney model on patient understanding of the percutaneous nephrolithotomy procedure: a preliminary study
Three-dimensional (3D) printed anatomical models can provide cognitive anatomical information. We aimed to study the effect of a 3D printed kidney model on patient understanding of kidney anatomy and the percutaneous nephrolithotomy (PCNL) procedure as well as the overall patient satisfaction with the model. Seven patients who underwent PCNL were enrolled in the study. Personalized 3D printed kidney models were constructed based on the patients’ computed tomography images. Patients completed two questionnaires regarding their understanding and satisfaction with the use of the 3D printed kidney model before and after using the model during informed consent. The mean age of the study population was 58.0 years. Comparison of patient understanding and satisfaction between the two questionnaires showed a general trend toward better understanding and improved satisfaction with use of 3D printed kidney models. Statistically significant results were seen for understanding of kidney anatomy, stone size, procedure, and satisfaction (p values 0.046, 0.025, 0.046, and 0.046, respectively). Five of the seven patients (71.4%) answered that the model was very useful. However, none of the patients answered that the cost was appropriate. In the current study, patients showed improved understanding of the kidney anatomy and the PCNL procedure and higher satisfaction with using the 3D printed kidney model during informed consent. With further studies using larger patient numbers and decreased production cost, using 3D printed kidney models has the potential to be a useful adjunct for patient understanding during PCNL.
- Open Access
- 1 January 2022
- Published by XMLink in Journal of Korean Medical Science
- Vol. 37 (15) , e115
Effect of Sedation Anesthesia With Intravenous Propofol on Transrectal Ultrasound-Guided Prostate Biopsy Outcomes
Kim HY, et al. J Korean Med Sci. 2022 Apr;37(15):e115. https://doi.org/10.3346/jkms.2022.37.e115
- 1 January 2022
- Published by XMLink in Journal of Korean Medical Science
- Vol. 37 (15) , e115
Open AccessEffect of Sedation Anesthesia With Intravenous Propofol on Transrectal Ultrasound-Guided Prostate Biopsy Outcomes
Kim HY, et al. J Korean Med Sci. 2022 Apr;37(15):e115. https://doi.org/10.3346/jkms.2022.37.e115
- Open Access
- 9 November 2020
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (11) , e0242006
A role for phosphodiesterase type 5 inhibitors in remodelling the urinary bladder after radiation exposure
Minimizing the toxicity of radiotherapy is challenging. We investigated the effects of a phosphodiesterase type-5 inhibitor (PDE5I) on the urinary bladder after pelvic radiotherapy. Eight rats were assigned to each group (group 1: control; group 2: radiation; group 3: radiation plus PDE5I). Radiation dose was 10 Gy/one fraction. Udenafil (20 mg/kg, daily for 4 weeks) was administered in group 3. Cystometry was performed 4 weeks after treatment, followed by real-time PCR for PDE5, vascular endothelial growth factor (VEGF), and endothelial nitric oxide synthase (eNOS) mRNA, western blotting for PDE5, cyclic GMP-dependent protein kinase (PRKG), VEGF164, Akt, eNOS and NADPH oxidase (NOX)-2 proteins, and immunohistochemistry for eNOS. The expression of both VEGF mRNA and eNOS mRNA was higher in group 3 than in group 2. VEGF and eNOS protein expression improved with PDE5I treatment. Akt protein phosphorylation was higher in group 3 than in group 2, but NOX-2 protein expression was lower in group 3 than in group 2. Immunohistochemistry showed that the mean density of arterioles expressing eNOS was higher in group 3 than in group 2. Cystometry revealed that the intercontraction interval was remarkably longer in group 3 than in group 2 but that the maximal voiding pressure was higher in group 2 than in group 3. Daily treatment with a PDE5I after radiotherapy may prevent bladder storage dysfunction, potentially due to its effects on vasodilation and angiogenesis and through minimizing tissue oxidative damage by means of the VEGF/Akt/eNOS pathway.
- 9 November 2020
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (11) , e0242006
Open AccessA role for phosphodiesterase type 5 inhibitors in remodelling the urinary bladder after radiation exposure
Minimizing the toxicity of radiotherapy is challenging. We investigated the effects of a phosphodiesterase type-5 inhibitor (PDE5I) on the urinary bladder after pelvic radiotherapy. Eight rats were assigned to each group (group 1: control; group 2: radiation; group 3: radiation plus PDE5I). Radiation dose was 10 Gy/one fraction. Udenafil (20 mg/kg, daily for 4 weeks) was administered in group 3. Cystometry was performed 4 weeks after treatment, followed by real-time PCR for PDE5, vascular endothelial growth factor (VEGF), and endothelial nitric oxide synthase (eNOS) mRNA, western blotting for PDE5, cyclic GMP-dependent protein kinase (PRKG), VEGF164, Akt, eNOS and NADPH oxidase (NOX)-2 proteins, and immunohistochemistry for eNOS. The expression of both VEGF mRNA and eNOS mRNA was higher in group 3 than in group 2. VEGF and eNOS protein expression improved with PDE5I treatment. Akt protein phosphorylation was higher in group 3 than in group 2, but NOX-2 protein expression was lower in group 3 than in group 2. Immunohistochemistry showed that the mean density of arterioles expressing eNOS was higher in group 3 than in group 2. Cystometry revealed that the intercontraction interval was remarkably longer in group 3 than in group 2 but that the maximal voiding pressure was higher in group 2 than in group 3. Daily treatment with a PDE5I after radiotherapy may prevent bladder storage dysfunction, potentially due to its effects on vasodilation and angiogenesis and through minimizing tissue oxidative damage by means of the VEGF/Akt/eNOS pathway.